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Abstract
In 2003 the final results of the Human Genome project revealed the details of our genome: 
a set of information about how human beings look, how we act, feel, think and develop. 
Soon after, other global collaborations such as the HapMap project and 1000 Genomes 
project were conducted. Although the main focus was to investigate the variability in hu-
man populations and the possible connections of certain variations to different conditions 
and diseases, these projects also had a great impact on the understanding of the genetic 
influence on sports performance. In parallel, improved methods for gene analysis and gene 
editing were developed. Based on those methods, it became possible to detect candidate 
genes responsible for different performance phenotypes and develop protocols similar to 
gene therapies for performance enhancement in athletes. This review covers developments 
in genetics, the overview of candidate genes associated with athletic performance, and ethi-








broken	records	closely	 linked	 to	scientific	and	 technological	advancements	
(Schneider	&	Rupert,	2006;	Camporesi	&	McNamee,	2018).	Athletes,	their	




































































networks	 with	 the	 overall	 physiology	 of	 the	 organism	 (Bassingthwaighte,	
2000:1043–1058).	However,	 designing	 a	model	 that	 could	 serve	 for	 better	
















peroxisome	 proliferator-activated	 receptor-delta	 (PPARδ)	 and	 cytosolic	
phosphoenolpyruvate	 carboxykinase	 (PEPCK-C)	 (Gould,	 2012:292–298,	
Fischetto	&	Bermon,	2013;	van	der	Gronde	et al.,	2013:670–678).
This	review	aims	to	cover	recent	developments	in	the	field	of	genetics,	pro-
vide	 a	 basic	 overview	 of	 candidate	 genes	 that	 are	 associated	with	 athletic	
performance	and	discuss	the	ethical	consequences	of	these	practices.







based	 on	 the	work	 of	Rosalind	E.	 Franklin,	made	 a	model	 of	DNA	 struc-
ture	(Watson	&	Crick,	1953:123–131).	This	led	to	research	that	considered	











































3. Detection of athletic performance-associated 





There	 are	 two	 approaches	 for	 the	 identification	 of	 genes	 associated	 with	
sports	performance.	Association	studies	often	use	one	of	the	next-generation	
























Today	 there	are	 three	gene-editing	 tools	with	different	 levels	of	specificity	
and	different	 approaches	 for	 eukaryotic	 cells	genome	editing:	 (1)	 zinc	 fin-







of	 the	DNA	sequence	 that	will	 be	 changed.	This	method	 is	 expensive	and	
takes	a	lot	of	time.	The	method	that	uses	TALENs	is	similar:	it	is	also	based	





success	 rate,	minimal	cost	and	minimal	 required	 time	for	execution.	Using	


















































and	while	 the	 harmful	 ones	 are	 usually	 removed	 from	 the	 population,	 the	
advantageous	ones	are	more	likely	to	be	passed	to	the	next	generation	–	this	
process	is	called	a	natural	selection	(Reece	et al.,	2013).	Mutations	that	re-
sulted	 in	 traits	which	 increased	 the	 ability	 to	 survive	 (fitness)	were	 under	
positive	selection,	and	among	especially	favoured	were	ones	responsible	for	
the	 adaptation	 to	 the	 environment	 –	 a	 latitude	 and	 a	 climate	 in	 particular.	
For	 that	 reason,	persons	originating	 from	diverse	geographical	 regions	dif-
fer	anthropometrically	and	in	body	composition,	which	may	predispose	their	
athletic	ability	in	a	particular	sport.	In	addition	to	the	appropriate	physique,	





2007:30–34;	 Bouchard,	 2012:347–352;	 dos	 Santos	 et al.,	 2016:600–612).	
Possible	influence	of	dozens	of	genes	and	hundreds	of	their	genetic	variants	
on	the	athletic	performance	has	been	investigated	over	the	last	decades	(van	

































first	 polymorphism	 found	 to	 be	 associated	with	 the	 physical	 performance.	
ACe	gene	provides	 instructions	for	 the	synthesis	of	angiotensin-converting	
enzyme	 (ACE),	which	converts	angiotensin	 I	 to	angiotensin	 II,	 a	vasocon-



















1964	Winter	Olympic	Games	 in	 Innsbruck,	who	won	 two	 gold	medals	 in	
country	skiing	as	well	as	a	silver	medal	in	the	4	×	10	kilometres	(km)	relay.	






















































tense	physical	activity	may	 result	 in	cardiac	changes:	 the	cyclists	with	 left	
































6. Ethical dilemmas of gene editing 














In	 the	 philosophy	 of	 sport	 literature	 thus	 far,	 problems	 relating	 to	 human	
genes,	 advancements	 of	 genetic	 technologies	 and	 gene	modification,	 have	















tage,	 paternalistic	 decision-making,	 harming	 athlete’s	 health,	 and	 coercion	
to	make	genome	adjustments.	Secondly,	there	is	a	group	of	issues	that	needs	
new	considerations	and	solutions,	where	the	history	of	the	discipline	doesn’t	
help.	The	movie	Gattaca	 (Niccol,	1997)	is	 the	perfect	example	of	 this,	be-
cause	 it	 has	 anticipated,	 predicted	 and	 problematized	 several	 issues	 of	 the	
kind,	also	showing	possible	mistakes,	problems,	and	limits.
6.1. Gene doping issues in the doping-debate 

















































Interestingly,	 Andy	Miah	 in	 the	 Encyclopedia	 of	 Global	 Bioethics	 (Miah,	
2016:2666–2676;	 ten	Have,	2016)	expressed	a	 strong	pro	enhancement	at-
titude	stating	that	“athletes	must	be	allowed	to	discover	new	means	of	per-
formance	 enhancement	 to	 take	 sport	 performances	 to	 new	 levels”	 (Miah,	
2016:2675).	Such	a	stand	seems	questionable	and	worrying	in	many	ways,	
from	medical	and	health,	ethical	and	moral,	to	scientific	and	social.
6.2. New ethical issues – new considerations and solutions


















sports-discipline	 (like	 in	gymnastics,	athletics,	 swimming,	etc.)	 in	as	many	
categories	and	sub-categories	as	differently	genetically	modified	competitors	
require.	 In	 such	 a	 case,	 each	 sport	 should	 have	 different	 (sub-)	 categories	
depending	on	the	enhancement	made,	either	physical	or	psychological,	with	







Other	 than	 changing	 somatic	 cells,	 changes	 in	 the	 genome	 that	might	 cre-
ate	superb	athletes	could	be	introduced	into	reproductive	cells.	In	that	case,	







































performance.	 It	 furthermore	 reveals	 information	 about	 the	 athlete’s	 family	
members.	In	the	last	edition	of	the	Encyclopedia	of	Global	Bioethics	Miah	
emphasised	that

























On	 the	other	hand,	 positive	outcomes	of	 such	 screening	 in	preventing	 and	
detecting	athlete’s	risk	injuries	(e.g.	sudden	cardiac	arrest,	concussion-related	
traumatic	brain	injuries,	overexertion	complications	related	to	the	sickle-cell	
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Genomsko preinačavanje i odabir na temelju gena povezanih 
sa sportsko-atletskim uspjehom – neki bio-etički problemi
Sažetak
Projekt ljudskoga genoma završen je 2003. godine, a njegovi su rezultati otkrili dotada nepo-
znate detalje o našem genomu: skupinu informacija o tome kako ljudska bića izgledaju, kako 
djeluju, osjećaju, misle i razvijaju se. Uskoro su ostvarene i druge međunarodne suradnje poput 
projekta HapMap i Projekta 1000 genoma. Unatoč tomu što su primarno bili usmjereni na 
istraživanje varijabilnosti u ljudskoj populaciji, kao i moguće povezanosti različitih varijacija s 
različitim stanjima i bolestima, ti su projekti također znatno utjecali na razumijevanje utjecaja 
gena na sportski uspjeh. Usporedno su razvijene poboljšane metode genske analize i genskoga 
preinačavanja na temelju kojih je postalo moguće utvrditi kandidatske gene odgovorne za razli-
čite fenotipe uspješnosti u sportu te razviti protokole slične genskim terapijama za poboljšanje 
sportskih natjecateljskih performansi sportaša. Ovaj rad daje pregled razvoja u genetici, pre-
gled kandidatskih gena povezanih sa sportskim natjecateljskim performansama te etičke dvojbe 
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Genomische Bearbeitung und Auswahl auf der Grundlage 
von Genen, die mit sportlichen Leistungen in Verbindung stehen – 
einige bioethische Fragen
Zusammenfassung
Im Jahr 2003 enthüllten die endgültigen ergebnisse des Humangenomprojekts die Details un-
seres Genoms: eine Reihe von Informationen darüber, wie Menschen aussehen, wie wir han-
deln, fühlen, denken und uns entwickeln. Bald darauf wurden weitere weltweite Kooperationen 
wie das HapMap-projekt und das 1000-Genome-projekt in die Tat umgesetzt. Obgleich das 
Hauptaugenmerk auf der Variabilität der menschlichen population und den möglichen Ver-
quickungen bestimmter Variationen mit verschiedenen Zuständen und Krankheiten lag, übten 
diese projekte auch eine große Wirkung auf das Verständnis des genetischen einflusses auf die 
sportliche Leistung aus. parallel dazu wurden verbesserte Methoden zur Genanalyse und Gen-
bearbeitung entwickelt. Basierend auf diesen Methoden wurde es machbar, Kandidatengene zu 
detektieren, die für verschiedene Leistungsphänotypen verantwortlich sind, und protokolle zu 
entwickeln, die Gentherapien zur Leistungssteigerung bei Sportlern ähneln. Dieser Aufsatz be-
handelt entwicklungen in der Genetik, den Überblick über Kandidatengene im Zusammenhang 
mit sportlicher Leistung und ethische Dilemmata bezüglich der Modifizierung des Genoms zur 
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La modification et la sélection du génome sur la base des gènes associés à 
la performance du sport athlétique – quelques problèmes bio-étiques
Résumé
en 2003, les résultats finaux du projet génome humain ont révélé les détails sur la structure de 
notre génome : un ensemble d’informations sur l’apparence physique de l’être humain, sur sa 
manière d’agir, de sentir, de penser, et de se développer. peu de temps après, d’autres collabora-
tions mondiales telles que le projet HapMap et le projet 1000 Genomes ont été menées à terme. 
Axés essentiellement sur la variabilité de la population humaine et sur les possibles liens de 
certaines variations avec différents états et maladies, ces projets ont toutefois eu un important 
impact sur notre manière de comprendre l’influence que les gènes exercent sur la performance 
sportive. en parallèle, des méthodes améliorées pour l’analyse du gène et la modification du 
gène ont été développées. Il est devenu possible sur la base de ces méthodes de détecter les 
gènes candidats responsables des différents phénotypes associés à la performance et de dé-
velopper des protocoles similaires aux thérapies géniques afin d’améliorer les performances 
chez les athlètes. Cet article passe en revue les développements en génétique, donne un aperçu 
général des gènes candidats associés à la performance athlétique et des dilemmes éthiques liés 
à la modification du génome dans le but d’améliorer la performance sportive.
Mots-clés
amélioration,	performance	sportive,	séquençage,	modification	du	génome,	gènes	candidats,	dilemmes	
éthiques
